Beck Bode LLC’s Concentrix CNXC Stock Holding History

Beck Bode LLC’s Portfolio CNXC Stock Details CNXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,769	Closed	-$628K	–	237
2022 Q1	$628K	Buy	+3,769	New	+$716K	0.14%	92

Other funds holding CNXC

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Beck Bode LLC's CNXC Position: Q2 2022 in Review

Beck Bode LLC sold out of Concentrix (CNXC) in Q2 2022, closing a stake of 3,769 shares — an estimated $628K sold.

Beck Bode LLC first reported a position in CNXC in Q1 2022 and held it in 1 quarter. The position peaked at $628K in Q1 2022. 324 funds tracked by Wall St. Rank hold CNXC as of Q2 2022.

Beck Bode LLC reported no remaining Concentrix position as of Q2 2022 after selling out during the quarter.
Beck Bode LLC sold 3,769 Concentrix shares in Q2 2022, an estimated $628K.
Beck Bode LLC first reported a position in Concentrix in Q1 2022 and held it in 1 quarter.
Beck Bode LLC's Concentrix position peaked at $628K in Q1 2022.
324 funds tracked by Wall St. Rank held Concentrix as of Q2 2022.

Based on Beck Bode LLC's 13F filing for Q2 2022, filed 29 Jul 2022.